PRO79 EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Autor:	F.J. Badia, M. Tort, J.L. Poveda, V. Tania, J. Shepherd
Rok vydání:	2019
Předmět:	Orphan drug medicine.medical_specialty business.industry Health Policy Family medicine Public Health Environmental and Occupational Health Medicine business Reimbursement
Zdroj:	Value in Health. 22:S855
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.2409
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0064740825653263b5cedbffbfe96ab8 https://doi.org/10.1016/j.jval.2019.09.2409 Zobrazit plný text záznamu Full Text from ScienceDirect